OmniLenz
Surgery-free ocular care (therapeutic contact lens)
CommercialActive
Key Facts
Indication
Surgery-free ocular care (therapeutic contact lens)
Phase
Commercial
Status
Active
Company
About NuVision Biotherapies
NuVision Biotherapies is a private, commercial-stage biotech focused on regenerative medicine for ophthalmology. Leveraging its patented Tereo® preservation technology, the company has launched two key products: Omnigen, a ready-to-use amniotic membrane graft for wound healing, and OmniLenz, a custom contact lens for rapid, non-surgical care. Founded on 15 years of translational research from the University of Nottingham, NuVision is led by an experienced team with deep medical device industry expertise and is building a portfolio to address significant unmet needs in ocular surface disease.
View full company profile